Merck

Diagonal Banks Another $125M for ‘Clustering’ Antibody Drugs

Merck Backs Off Revolution After Failing To Agree on Price: WSJ

Biopharma M&A Heats Up, Rare Diseases Win Three Approvals, Wave Crashes

AbbVie, Amgen, Lilly Lead Calls for FDA To Update Post-Approval Change Rules

Hims & Hers Expands Personalized Digital Healthcare Platform

How Merck Plans to Set a Buffer for Keytruda's Patent Cliff

FDA Lifts Partial Hold on Merck, Daiichi's Phase 3 Lung Cancer Study

S&P 500, Nasdaq Nab Best Weeks Since November: Stock Market Today

Breast Cancer Treatments Heat Up: Six Therapies Poised to Transform Patient Outcomes

Healthtech, Biotech: Why the UK Is Emerging as an Essential Hub

Servier Signs €1bn-Plus AI Pact with Iktos

FDA Sets Feb. 1 Launch Date for PreCheck Pilot To Strengthen Domestic Supply Chain

Former Sen. Ben Sasse Shines the Spotlight on a Possible Breakthrough for Pancreatic Cancer

Eli Lilly to Acquire Kelonia Therapeutics in $7 B Cash Deal

Merck Splits Operations to Separate Oncology From Non-Cancer Drugs

This Pill May Help Pancreatic Cancer Patients Live Longer

‘Almost Like a Religion’: Pfizer CEO Slams RFK Jr.’s 'Anti-Science' Vaccine Policies

Flagship CEO Calls Out Attacks on Science, Warns of China Dominance

PharmaShots Quarterly Outlook: The Forces Reshaping Biopharma in Q1 2026

Pfizer’s Oncology Sales Poised for Growth Ahead of Q1 Earnings

Permittivity Provides an In-Line Cell Health Early-Warning System

What’s in a Name? Moderna’s “Vaccine” Vs. “Therapy” Dilemma

Pfizer's Oncology Portfolio Targets Growth Ahead of May 5 Earnings

Toward Equitable Access to Cell and Gene Therapies: Rethinking Co-Payments

Frontier Medicines Grants Ex-China Rights of FMC-220 to LG Chem

Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus

Interna Therapeutics Collaborates with Daiichi Sankyo to Develop MNM-Based Targeted Delivery Technologies

TotalEnergies Inks 1GW Google Solar Deal

Neurocrine Nabs Rare Obesity Disorder Drug in ‘Surprising’ $2.9B Soleno Deal

IO Shuts Down Following Regulatory Roadblocks

IDEAYA and Servier’s Eye Cancer Drug Heads to FDA After Delivering ‘Best in Class’ Efficacy

The Top 10 PharmTech Videos of 2025

Peter Thiel’s Big Bet on Solar-Powered Cow Collars

Merck and Mayo Clinic Partner on AI-Driven Drug Research

Akeso's Cadonilimab Shows Survival Gain in Phase II Pancreatic Cancer Trial

Merck Receives the EC Approval for Keytruda, Plus CT ± Avastin to Treat PD-L1+ Pt-Resistant Ovarian Carcinoma

Why Owning the Learning Loop Matters More Than Owning the Lab

Kelun-Biotech to Unveil Three Oncology Trial Results at 2026 ASCO Meeting

What Makes Veeva Systems Inc (VEEV)’s Future Bright?

Merck to Acquire Terns Pharmaceuticals for $6.7 B, Accelerating M&A Ahead of Keytruda Patent Expiry

Proteasomes: A Novel Approach to Target the Immune System

Top Biotech Deals in March 2026

Merck Steps up as 'Meaningful Competitor' To Gilead with HIV Pill Approval

STAT+: GSK Picks up Pulmonary Hypertension Drug with 35Pharma Acquisition

Report Says MSD Is in Talks to Buy Revolution Meds

FDA Grants Priority Review for Merck's KEYTRUDA‑Padcev Combo in Muscle‑Invasive Bladder Cancer

Biotech’s Next Chapter: Asset-Centric Deals and Shifting Alpha at JPM 2026

GSK Joins Growing PD-1 SubQ Push With Alteogen Alliance Worth up to $285M+

An Analysis of International Space Station Experiments

Synthesia Announces Major Hiring Push, Opens Three New Offices

Merck to Acquire Cidara Therapeutics to Advance Universal Flu Vaccine

Merck Exercises Option to License Evaxion's EVX‑B3 Infectious Disease Vaccine Candidate

Solve Therapeutics Raises $120M in Oversubscribed Funding Round

Merck to Acquire Terns Pharmaceuticals for $6.7B